当前位置: X-MOL 学术Lancet Diabetes Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Is the new treatment for Cushing's disease too sweet?
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2017-10-11 , DOI: 10.1016/s2213-8587(17)30341-8
Ashley Grossman

Cushing's disease, pituitary-dependent Cushing's syndrome, is a rare disorder with an incidence in the region of 1–2 cases per million population per year worldwide1—but is of interest far beyond its rarity: it causes specific problems in diagnosis and can be difficult to treat effectively, but successful therapy can show spectacular clinical transformations. It is most often caused by a small corticotroph tumour, often just a few mm in diameter. In classic cases it presents with florid unmistakable manifestations, although much more subtle cases are increasingly being recognised.

中文翻译:

库欣氏病的新疗法太甜吗?

库欣病(垂体依赖型库欣综合征)是一种罕见的疾病,在全世界每年每百万人口中发生1-2例左右1,但它的意义远非其稀有:它引起诊断方面的特定问题,并且可以很难有效治疗,但是成功的治疗可以显示出惊人的临床转变。它最常见是由皮层营养小肿瘤引起的,直径通常只有几毫米。在经典案例中,它呈现出无懈可击的丰富表现,尽管越来越多的微妙案例被人们所认识。
更新日期:2017-12-20
down
wechat
bug